Javascript must be enabled to continue!
Anonymous Equity Research
View through CrossRef
Crowdsourced financial information platforms often allow content contributors to publish equity research anonymously. This study examines whether investors value or discount information in anonymous equity research. In the short window around research releases, we find that investors’ stock price reaction to anonymous research is muted in comparison to non-anonymous research. Consistent with credibility concerns influencing investor response, we document that this discount to anonymous research dissipates as the monitoring of content contributors intensifies and as authors develop a reputation for high-quality reporting. In addition, we perform a content analysis on the research reports and find that the muted market reaction to anonymous equity research is robust to controlling for textual attributes of information content, further supporting our inference that investors’ are concerned about the credibility of anonymous equity research.
Title: Anonymous Equity Research
Description:
Crowdsourced financial information platforms often allow content contributors to publish equity research anonymously.
This study examines whether investors value or discount information in anonymous equity research.
In the short window around research releases, we find that investors’ stock price reaction to anonymous research is muted in comparison to non-anonymous research.
Consistent with credibility concerns influencing investor response, we document that this discount to anonymous research dissipates as the monitoring of content contributors intensifies and as authors develop a reputation for high-quality reporting.
In addition, we perform a content analysis on the research reports and find that the muted market reaction to anonymous equity research is robust to controlling for textual attributes of information content, further supporting our inference that investors’ are concerned about the credibility of anonymous equity research.
Related Results
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
619. Pharmacokinetic-Pharmacodynamic (PK-PD) Target Attainment Analyses to Support Epetraborole Dose Selection for the Treatment of Patients with Mycobacterium avium Complex (MAC) Lung Disease
Abstract
Background
Epetraborole (EBO) is an orally available, bacterial leucyl transfer RNA synthetase inhibitor that concentra...
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
LB2306. Population Pharmacokinetic (PPK), Pharmacokinetic/Pharmacodynamic attainment (PTA), and Clinical Pharmacokinetic/Pharmacodynamic (PK/PD) Analyses for Sulbactam-Durlobactam (SUL-DUR) to Support Dose Selection for the Treatment of Acinetobacter baum
Abstract
Background
SUL-DUR is a β-lactam/β-lactamase inhibitor combination in development for the treatment of ABC infections, ...
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
593. Population Pharmacokinetic Model Development for Epetraborole and Mycobacterium avium Complex (MAC) Lung Disease Patients Using Data from Phase 1 and 2 Studies
Abstract
Background
Epetraborole (EBO), an orally available bacterial leucyl transfer RNA synthetase inhibitor with potent activ...
Accelerating Birth Equity using Collaborative Systems Mapping
Accelerating Birth Equity using Collaborative Systems Mapping
Abstract
Background
Recognizing the complexity of cross-sector collaboration, holistic and innovative approaches are required to achieve birth equity. This project applied...
MEMBANGUN BRAND EQUITY UMKM IKAN ASAP MENGGUNAKAN TEKNOLOGI AUGMENTED REALITY MELALUI LITERASI PEMASARAN
MEMBANGUN BRAND EQUITY UMKM IKAN ASAP MENGGUNAKAN TEKNOLOGI AUGMENTED REALITY MELALUI LITERASI PEMASARAN
Abstrak
UMKM merupakan salah satu roda penggerak perekenomian nasional. Terbukti bahwa UMKM telah membantu 61,97% PDB Indonesia. Namun sayangnya, masih banyak produsen yang memili...
Evidence for Equity: Introducing Betta Health Equity
Evidence for Equity: Introducing Betta Health Equity
Abstract
There are moments in history that we recognize, only with hindsight, as inflection points—chapters when the arc of progress bends toward justice. We believe the laun...
Analyzing the Effect of Debt on the Equity Valuation of Oil and Gas Producers in the Current Commodity Price Cycle
Analyzing the Effect of Debt on the Equity Valuation of Oil and Gas Producers in the Current Commodity Price Cycle
Abstract
While a severe drop in commodity prices was expected to have an adverse valuation impact on oil & gas producers, the variability of this impact across t...
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
592. Impact of Elevated MIC Values on Echinocandin Pharmacokinetic-Pharmacodynamic (PK-PD) Candida glabrata Target Attainment (TA)
Abstract
Background
Given the increasing prevalence of non-albicans Candida species, including C. glabrata and C. auris, which h...

